Evidence map›Paper›PMID 33511018›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Biomimetic Anti-PD-1 Peptide-Loaded 2D FePSe

Xueyang Fang, Xianlin Wu, Zhendong Li, Lijun Jiang, Wai-Sum Lo, Guanmao Chen, Yanjuan Gu, Wing-Tak Wong

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Precision USPIO-PEG-SLeInternational journal of nanomedicine · 2024
    Article
  15. Article
  16. Biodegradable FePSJournal of nanobiotechnology · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Recent advances in 2D material-based phototherapy.Frontiers in bioengineering and biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Xueyang FangDepartment of Applied Biology and Chemical Technology The Hong Kong Polytechnic University Hong Kong SAR P. R. China.
Xianlin WuInstitute of Clinical Medicine The First Affiliated Hospital of Jinan University Guangzhou 510632 P. R. China.
Zhendong LiHepatobiliary Surgery Department The First Affiliated Hospital of Jinan University Guangzhou 510632 P. R. China.
Lijun JiangDepartment of Applied Biology and Chemical Technology The Hong Kong Polytechnic University Hong Kong SAR P. R. China.
Wai-Sum LoDepartment of Applied Biology and Chemical Technology The Hong Kong Polytechnic University Hong Kong SAR P. R. China.
Guanmao ChenMedical Imaging Center First Affiliated Hospital of Jinan University Guangzhou 510630 P. R. China.
Yanjuan GuDepartment of Applied Biology and Chemical Technology The Hong Kong Polytechnic University Hong Kong SAR P. R. China.
Wing-Tak WongDepartment of Applied Biology and Chemical Technology The Hong Kong Polytechnic University Hong Kong SAR P. R. China.ORCID https://orcid.org/0000-0002-3453-1825
Hong Kong Polytechnic University · HKFirst Affiliated Hospital of Jinan University · CNJinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metal phosphorous trichalcogenides (MPX

Indexed as

cancer photothermal–immune therapyFePSe3 nanosheetsmetal phosphorus trichalcogenidesmultimodal imagingPD‐1 blockade

Identifiers

PMID33511018
PMCPMC7816711
OpenAlexW3107081304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.